Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Cash & Current Investments (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Cash & Current Investments for 16 consecutive years, with $23.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Current Investments rose 29.74% year-over-year to $23.7 million, compared with a TTM value of $23.7 million through Sep 2025, up 29.74%, and an annual FY2024 reading of $21.6 million, up 97.55% over the prior year.
  • Cash & Current Investments was $23.7 million for Q3 2025 at Rockwell Medical, up from $18.4 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $46.1 million in Q1 2021 and bottomed at $8.6 million in Q1 2024.
  • Average Cash & Current Investments over 5 years is $21.4 million, with a median of $18.4 million recorded in 2025.
  • The sharpest move saw Cash & Current Investments plummeted 78.54% in 2022, then skyrocketed 101.08% in 2025.
  • Year by year, Cash & Current Investments stood at $22.4 million in 2021, then fell by 4.22% to $21.5 million in 2022, then tumbled by 49.12% to $10.9 million in 2023, then soared by 97.55% to $21.6 million in 2024, then increased by 9.74% to $23.7 million in 2025.
  • Business Quant data shows Cash & Current Investments for RMTI at $23.7 million in Q3 2025, $18.4 million in Q2 2025, and $17.3 million in Q1 2025.